IRIS - Res&Arch Institutional Research Information System - Research & Archive

BIANCHI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.656
EU - Europa 2.839
AS - Asia 2.496
SA - Sud America 442
AF - Africa 73
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 9.512
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.598
SG - Singapore 1.192
IT - Italia 568
UA - Ucraina 399
IE - Irlanda 394
CN - Cina 369
BR - Brasile 335
SE - Svezia 294
HK - Hong Kong 292
VN - Vietnam 283
RU - Federazione Russa 269
DE - Germania 220
FR - Francia 185
FI - Finlandia 140
RO - Romania 113
GB - Regno Unito 93
IN - India 75
KR - Corea 58
AR - Argentina 45
BD - Bangladesh 37
CZ - Repubblica Ceca 33
TR - Turchia 33
CA - Canada 27
BE - Belgio 25
IQ - Iraq 24
PL - Polonia 24
CH - Svizzera 18
CO - Colombia 18
PK - Pakistan 17
EC - Ecuador 16
MX - Messico 16
CI - Costa d'Avorio 15
NL - Olanda 15
UZ - Uzbekistan 15
ZA - Sudafrica 15
ID - Indonesia 13
JP - Giappone 13
AT - Austria 11
GR - Grecia 11
PH - Filippine 11
ES - Italia 10
MA - Marocco 9
VE - Venezuela 9
LB - Libano 8
SA - Arabia Saudita 8
PE - Perù 7
TN - Tunisia 7
IL - Israele 6
AZ - Azerbaigian 5
EG - Egitto 5
JO - Giordania 5
LT - Lituania 5
PS - Palestinian Territory 5
ET - Etiopia 4
EU - Europa 4
PY - Paraguay 4
BO - Bolivia 3
CL - Cile 3
CR - Costa Rica 3
DZ - Algeria 3
GE - Georgia 3
HU - Ungheria 3
KE - Kenya 3
MY - Malesia 3
NG - Nigeria 3
OM - Oman 3
AE - Emirati Arabi Uniti 2
HR - Croazia 2
IR - Iran 2
JM - Giamaica 2
KW - Kuwait 2
LC - Santa Lucia 2
LR - Liberia 2
PA - Panama 2
QA - Qatar 2
RS - Serbia 2
TH - Thailandia 2
UY - Uruguay 2
AU - Australia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CU - Cuba 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
MN - Mongolia 1
MR - Mauritania 1
MZ - Mozambico 1
Totale 9.506
Salva come PNG Salva come JPEG
Città #
Singapore 880
Chandler 427
Dublin 394
Perugia 326
Hong Kong 288
San Jose 248
San Mateo 232
Jacksonville 192
Ashburn 165
Boardman 157
Dong Ket 135
Santa Clara 129
Bucharest 111
Beijing 100
Wilmington 97
Medford 94
Princeton 93
Moscow 91
Altamura 89
Redmond 89
Munich 82
Lauterbourg 80
Ann Arbor 77
Andover 70
Des Moines 70
Lawrence 68
Seoul 57
Ho Chi Minh City 56
Los Angeles 54
New York 50
Falls Church 45
The Dalles 35
Dearborn 34
São Paulo 32
Turku 32
Hanoi 30
Orem 30
Woodbridge 28
Chennai 26
Pisa 26
Saint Petersburg 26
Brussels 25
Dallas 23
Norwalk 22
Helsinki 21
Piscataway 21
Brno 18
Council Bluffs 18
Boston 17
Chicago 17
Frankfurt am Main 17
Warsaw 17
Fremont 16
Nuremberg 16
Abidjan 15
Brooklyn 15
San Paolo di Civitate 14
Milan 13
Olomouc 13
Poplar 13
Tokyo 12
Denver 11
Izmir 11
Shanghai 11
Atlanta 10
Baghdad 10
Guangzhou 10
Haiphong 10
London 10
Manchester 10
San Francisco 10
Belo Horizonte 9
Johannesburg 9
Mumbai 9
Phoenix 9
San Diego 9
Seattle 9
Fortaleza 7
Medellín 7
Montreal 7
Nanjing 7
Paris 7
Ankara 6
Buenos Aires 6
Columbus 6
Den Haag 6
Hanover 6
Houston 6
Istanbul 6
Jinan 6
Joinville 6
Nagpur 6
Rio de Janeiro 6
Stockholm 6
Tashkent 6
Tianjin 6
Toronto 6
Wuhan 6
Buffalo 5
Cape Town 5
Totale 5.986
Salva come PNG Salva come JPEG
Nome #
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 211
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 204
A GpC-Rich Oligonucleotide Acts on Plasmacytoid Dendritic Cells To Promote Immune Suppression. 203
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 200
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 190
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 183
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 182
Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1 175
87P - Towards the identification of the mechanism of action of antitumor 1-methyl-D-tryptophan 158
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 155
IL‐35Ig–expressing dendritic cells induce tolerance via Arginase 1 153
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy 148
A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815. 147
CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum- or helper peptides in priming for skin test reactivity to a P815AB-related peptide 144
Dendritic cells expressing ectopic IL-35Ig induce IDO-related tolerance in vivo. 144
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 141
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 136
The TGF-β/IDO axis in infectious tolerance. 135
Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: search for serologically defined antigens at the clonal level. 130
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 129
CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. 128
Antigen-specific immunoregulation by IL-35Ig-transfected dendritic cells 127
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes 124
Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells. 122
Preclinical discovery and development of fingolimod for the treatment of multiple sclerosis 121
[Transfer in vivo of cytotoxic immune lymphocytes obtained in vitro in primary culture against a murine lymphoma antigenically altered by DTIC]. 120
Ectopic expression of IL-35Ig by dendritic cells induces tolerance via Arginase 1. 120
CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig. 119
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 117
[Experimental models of immunochemotherapeutic synergism: study of the influence of the treatment schedule]. 117
CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice 116
Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes. 116
Adoptive immunotherapy of intracerebral murine lymphomas: role of different lymphoid populations. 114
Autocrine IL-12 is involved in dendritic cell modulation via CD40 ligation 113
IL-12 acts selectively on CD8a- dendritic cells to enhance presentation of a tumor peptide in vivo 112
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 110
CD40 ligand and CTLA-4 are reciprocally regulated in the Th1 cell proliferative response sustained by CD8+ dendritic cells. 108
A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state 106
O6-alkylguanine-DNA alkyltransferase attenuates triazene-induced cytotoxicity and tumor cell immunogenicity in murine L1210 leukemia 105
Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide. 102
Modulation of tryptophan catabolism by regulatory T cells 101
Immunobiological aspects of the nude mouse model relative to human cancer chemosensitivity tests. 101
CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells 99
IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. 97
Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12 97
Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. 97
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. 97
Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine 96
T cell apoptosis by tryptophan catabolism 96
Towards the identification of a tolerogenic signature in IDO-competent dendritic cells 96
A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice 96
Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells. 95
CTLA-4-Ig regulates tryptophan catabolism in vivo. 93
Ectopic expression of IL-35Ig by dendritic cells induces IDO-related tolerance in vivo 92
Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. 91
Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma 90
IL-12 ACTS DIRECTLY ON DC TO PROMOTE NUCLEAR LOCALIZATION OF NF-kB AND PRIMES DC FOR IL-12 PRODUCTION 88
Immunomodulatory properties of ribavirin in the mouse. 87
Use of a skin test assay to determine tumor-specific CD8+ T cell reactivity 87
Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement 87
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells 86
Tryptophan catabolism generates autoimmune-preventive regulatory T cells 85
IL-12 induces SDS-stable class II (alpha beta) dimers in murine dendritic cells 85
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. 85
Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. 84
Delayed-type hypersensitivity to tumor antigens co-expressed with immunogenic determinants induced by xenogenization. 84
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 82
IL-23 and IL-12 have overlapping but distinct effects on murine dendritic cells. 81
Dendritic cells, CD4+ lymphocytes and IL-12 in an experimental model of antitumor immunotherapy 80
Drug-induced immunogenic changes of murine leukemia cells: dissociation of onset of resistance and emergence of novel immunogenicity. 80
Systemic adoptive immunotherapy of a highly immunogenic murine lymphoma growing in the brain. 80
Immunogenic properties of retroviral protein p15E from drug-treated murine mastocytoma P815 78
Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. 77
Inhibition of murine lymphoma growth by adoptive transfer of lymphocytes sensitized to a xenogenized tumor variant. 77
Immunogenicity of tumor peptides: importance of peptide length and stability of peptide/MHC class II complex 76
Endotoxin tolerance as a novel defense strategy in infectious diseases: the role of tryptophan catabolism 76
IL-12 is both required and sufficient for initiating T-cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells 74
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 72
Tumor-specific L3T4+ and Lyt-2+ lymphocytes in mice primed to mutagenized cell variants. 71
Intracerebral adoptive immunotherapy of a murine lymphoma antigenically altered by drug treatment in vivo. 71
Immune system to brain signaling and vice versa: The role of tryptophan and glutamate 66
Dendritic cells and interleukin 12 as adjuvants for tumor-specific vaccines. 65
PROTEASOME INHIBITION IN pDCs CONFERS AN IDO-DEPENDENT IMMUNOREGULATORY PHENOTYPE 61
Induction of tumor suppression and delayed-type footpad reaction by transfer of lymphocytes sensitized to a xenogenized tumor variant. 60
Molecular and genomic aspects of xenogenizing-alkylating drugs. 60
O6-methylguanine-DNA methyltransferase activity and induction of novel immunogenicity in murine tumor cells treated with methylating agents. 58
Tryptophan catabolism in nonobese diabetic mice. 58
Indoleamine 2,3-dioxygenase: from catalyst to signaling function 56
IFN-gamma inhibits presentation of a tumor/self peptide by CD8 alpha- dendritic cells via potentation of the CD8 alpha+ subset 54
Indoleamine 2,3 dioxygnenase: as an inducer and amplifier of regulatory T cell functions. 49
IDO-TARGETING INTERVENTION IN AUTOIMMUNE DIABETES BY PROTEASOME INHIBITION 47
Th1 and Th2 cell clones to poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivo 47
The role of IL-12 in the induction of an immune response to a tumor/self peptide: prevention and reversion of anergy. 37
Totale 9.770
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.881
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021151 0 0 0 0 0 0 0 0 0 0 0 151
2021/20221.141 15 160 12 52 56 32 14 277 108 88 107 220
2022/20231.462 107 249 15 116 137 187 0 77 515 5 41 13
2023/2024559 35 85 15 9 3 9 150 17 50 12 63 111
2024/20251.340 23 113 98 72 160 62 47 88 231 85 208 153
2025/20263.166 189 240 161 421 365 315 535 229 327 275 78 31
Totale 9.770